BSE filing, NSE: INTERCONTINENTAL. Summary written from the filing by ALFA Finder's alert engine.
Medico Intercontinental Ltd: key numbers
- Share price
- ₹25.00
- Market cap
- ₹25.00 Cr
- Revenue (annual)
- ₹84.08 Cr
- Net profit (annual)
- ₹-3.20 Cr
- P/E (TTM)
- -6.3×Sector 43.1×
- Promoter holding
- 58.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Intercontinental Ltd
All →Medico Intercontinental Annual General Meeting
Medico Intercontinental Limited conducted its 42nd Annual General Meeting on September 30, 2026. Shareholders considered the adoption of FY26 financial statements and approved several related party transactions.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4 Cr
Medico Intercontinental Board Meeting Date
Medico Intercontinental Ltd scheduled a board meeting on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the June quarter.
Medico Intercontinental Promoter Buying
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares (1.37%) of Medico Intercontinental via open market purchase. Total promoter group holding increased to 60.48%.
Medico Intercontinental Promoter Buying: ₹0.54 Cr
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares of Medico Intercontinental via open market. The transaction, valued at Rs. 0.54 Crore, increased his stake to 47.77%.
- Value
- ₹0.54 Cr
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.